With Spain's economy on the road to recovery after experiencing a period of financial crisis, multinational companies are once again seeing the country as a prime investment destination.   The top 20 pharmaceutical companies in Spain -- combining the prescription and consumer market -- in the year up to April 2018 according to IQVIA ranked by market share. GSK leads the way with 3.8% market share, followed closely by Cinfa with 3.7% and Sanofi-Aventis with 3.5%. The top 20 pharmaceutical companies in Spain -- prescription market -- in the year up to April 2018 according to IQVIA ranked by market share. GSK is in the lead again with 5.3% market share, followed by Merck Sharp Dohme with 4.3% and Sanofi-Aventis with 4.2%. The top 20 pharmaceutical companies in Spain -- consumer market -- in the year up to April 2018 according to IQVIA ranked by market share. Johnson & Johnson lead the way with 4.4% market share, followed by GSK with 3.3% and Bayer with 3.2%.